Growing community of inventors

Vaucluse, Australia

Fabienne MacKay

Average Co-Inventor Count = 4.29

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 154

Fabienne MacKayJeffrey L Browning (7 patents)Fabienne MacKayPascal Schneider (5 patents)Fabienne MacKayChristine Ambrose (5 patents)Fabienne MacKayJurg Tschopp (5 patents)Fabienne MacKayJeffrey Thompson (4 patents)Fabienne MacKayPaul David Rennert (2 patents)Fabienne MacKayPaula S Hochman (2 patents)Fabienne MacKaySusan L Kalled (1 patent)Fabienne MacKayFabienne MacKay (8 patents)Jeffrey L BrowningJeffrey L Browning (43 patents)Pascal SchneiderPascal Schneider (18 patents)Christine AmbroseChristine Ambrose (17 patents)Jurg TschoppJurg Tschopp (10 patents)Jeffrey ThompsonJeffrey Thompson (16 patents)Paul David RennertPaul David Rennert (33 patents)Paula S HochmanPaula S Hochman (20 patents)Susan L KalledSusan L Kalled (15 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Biogen Ma Inc. (3 from 250 patents)

2. Biogen Idec Ma Inc. (3 from 216 patents)

3. Biogen, Incorporated (1 from 130 patents)

4. Apoxis S.a. (1 from 7 patents)

5. Topotarget Switzerland Sa (1 from 3 patents)

6. Biogen Idcc Ma Inc. (1 from 1 patent)


8 patents:

1. 10494416 - Methods of modulating immune responses using BCMA polypeptide

2. 9650430 - Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)

3. 9545086 - BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders

4. 8828669 - Methods of screening for a compound that inhibits the interaction between BAFF and BCMA

5. 7309492 - Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus

6. 7255854 - Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases

7. 7083785 - Methods of treatment by administering an anti-BCMA antibody

8. 6869605 - BAFF, inhibitors thereof and their use in the modulation of B-cell response

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/30/2025
Loading…